Autoimmune Disease Treatment Sends Pharma Stock Surging 71%
Are you looking for the next big growth catalyst in the biotechnology sector? Look no further than Dianthus Therapeutics, a clinical stage company that is poised for significant growth. Oppenheimer recently initiated coverage of Dianthus … Read more